One single dose

Under the agreement, Johnson & Johnson will manufacture 100 million doses of its coronavirus vaccine in the U.S. for $1 billion as soon as it clears the FDA’s emergency use approval. That averages about $10 per dose, which is the cheapest among vaccine candidates on BARDA’s purchase list.